Edition:
United Kingdom

Melinta Therapeutics Inc (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

1.32USD
8:59pm GMT
Change (% chg)

$-0.08 (-5.71%)
Prev Close
$1.40
Open
$1.40
Day's High
$1.47
Day's Low
$1.29
Volume
118,614
Avg. Vol
110,701
52-wk High
$17.50
52-wk Low
$1.29

Chart for

About

Melinta Therapeutics, Inc. develops and commercializes novel antibiotics designed to provide therapeutic solutions. The Company’s lead product is Baxdela, an antibiotic approved by the United States food and drug administration (FDA) for use in the treatment of acute bacterial skin and skin structure infections (ABSSSI). The... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $166.71
Shares Outstanding(Mil.): 52.51
Dividend: --
Yield (%): --

Financials

  MLNT.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.89 -- --
ROI: -48.67 9.01 14.96
ROE: -54.82 10.15 16.52

Earnings vs. Estimates